Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE

AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE

Standard Dose
5MG; 20MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE is listed in Drugs@FDA under application 078652 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE Form and strength CAPSULE; ORAL - 5MG; 20MG Sponsor ZYDUS PHARMS USA INC Submission history Latest submission status date: 2013-03-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE is listed in Drugs@FDA under application 078652 (ANDA). Marketing status: None (Tentative Approval) Active ingredient AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE Form and strength CAPSULE; ORAL - 5MG; 20MG Sponsor ZYDUS PHARMS USA INC Submission history Latest submission status date: 2013-03-28 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.